Type 1 Diabetes Trial, Recruiting NCT07470593 Sponsor: University Hospital, Strasbourg, France Condition: Type 1 Diabetes
Back to Type 1 Diabetes

Type 1 Diabetes Trial, Recruiting

NCT07470593
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are 18 years of age or older
  • People who have diabetes that requires insulin, including type 1 diabetes, diabetes caused by chronic pancreatitis, a genetic form of diabetes called MODY, or diabetes related to cystic fibrosis
  • People who have completed a full pancreatic islet transplant procedure — this includes transplant of islets alone, islet transplant after a kidney transplant, or islet and kidney transplant at the same time — where either a sufficient number of islet cells were transplanted, or the person was able to stop using insulin after the transplant (confirm with trial site for specific cell number thresholds)
  • People who have agreed to allow their health data to be used for this research

Who may not be able to join:

  • People who are unwilling to wear a continuous glucose monitoring device (a small sensor that tracks blood sugar levels)
  • People who received an islet transplant using their own pancreatic tissue (rather than a donor's)
  • People who are not able to give informed consent, for example due to difficulty understanding the study information
  • People who are under a form of legal protection ordered by a court (confirm with trial site for clarification on the specific legal categories)
  • People who are under legal guardianship or curatorship (a formal arrangement where another person or authority manages their affairs)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 12 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Luc RAKOTOARISOA, Dr, HOPITAUX UNIVERSITAIRES DE STRASBOURG

Phone: 0033 3 88 11 54 30

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
15 December 2025
Est. completion
15 December 2029

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Time in Tight Range (70-140 mg/dL) >70% without severe hypoglycemia over 1 year.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov